Log in

Start Your Membership Now

April 18, 2011 On May 2, 2011, the Illinois Department of Healthcare and Family Services implemented changes to the Medicaid preferred drug list that include limitations on access to several antipsychotic medications. Invega Sustenna has been changed to a preferred medication, but a prior authorization is required; and Abilify, Fazaclo, Invega ER, Seroquel, and Seroquel XR have been moved to non-preferred status. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

Market Intelligence Resource | April 18, 2011

Preferred Drug List Changes for Atypical Antipsychotics, Anticonvulsants, Antidepressants—SSRIs, Antidepressants—Other, and Stimulants/ADHD Agents

April 18, 2011 On May 2, 2011, the Illinois Department of Healthcare and Family Services implemented changes to the Medicaid preferred drug list that include limitations on access to several antipsychotic medications. Invega Sustenna has been changed to a preferred medication, but a prior authorization is required; and Abilify, Fazaclo, Invega ER, Seroquel, and Seroquel XR have been moved to non-preferred status. Download the Report . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
Log In
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member
If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.